Ma Han-ying, Zhao Tie-fu, Zhang Yin-feng, Shi Hong-zhi, Han Hong-ya, Zhou Yu-jie, Dick Ronald J
12th Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Zhonghua Yi Xue Za Zhi. 2010 Aug 24;90(32):2255-8.
To evaluate the effect of statin pretreatment on prognosis of octogenarian patients with coronary heart disease with percutaneous coronary intervention (PCI).
A total of 90 patients aged at 85 years old and over with coronary heart disease (CAD) undergoing stenting were enrolled. The duration of statin, hospitalization and one-year clinical follow-up outcome including all-cause mortality, major adverse cardiac event (MACE), stroke and other major hemorrhages were collected and analyzed.
Among these patients, 33 (36.7%) received a statin pre-treatment for at least 2 days and 57 (63.3%) did not. Patients on a statin pre-treatment were more likely to have hypertension, hyperlipidemia and a history of myocardial infraction and PCI. The procedure characteristics were similar between two groups. Despite the higher risk profile, the patients on a statin pre-treatment had a lower hospitalization MACE rate (3.0% vs 10.5%, P = 0.05). However, at one year, the patients on a statin pre-treatment had a similar MACE rate (6.1% vs 3.8%, P = 0.07) as the other group.
The statin pretreatment in octogenarian CAD patients with PCI may be associated with a reduced hospitalization MACE rate.
评估他汀类药物预处理对80岁及以上冠心病患者经皮冠状动脉介入治疗(PCI)预后的影响。
共纳入90例年龄在85岁及以上接受支架置入术的冠心病(CAD)患者。收集并分析他汀类药物使用时间、住院时间以及包括全因死亡率、主要不良心脏事件(MACE)、中风和其他重大出血在内的一年临床随访结果。
在这些患者中,33例(36.7%)接受了至少2天的他汀类药物预处理,57例(63.3%)未接受。接受他汀类药物预处理的患者更易患高血压、高脂血症且有心肌梗死和PCI病史。两组的手术特征相似。尽管风险更高,但接受他汀类药物预处理的患者住院期间MACE发生率较低(3.0%对10.5%,P = 0.05)。然而,在一年时,接受他汀类药物预处理的患者与另一组的MACE发生率相似(6.1%对3.8%,P = 0.07)。
80岁冠心病PCI患者的他汀类药物预处理可能与住院期间MACE发生率降低有关。